Market Closed -
Nasdaq
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
38.42
USD
|
+0.92%
|
|
-0.44%
|
-40.82%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,252
|
4,582
|
3,410
|
3,739
|
2,227
|
-
|
-
|
Enterprise Value (EV)
1 |
4,088
|
4,406
|
3,084
|
3,623
|
2,113
|
2,116
|
2,088
|
P/E ratio
|
323
x
|
507
x
|
-116
x
|
-2,164
x
|
-72.5
x
|
172
x
|
72.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
30.4
x
|
16.5
x
|
8.89
x
|
7.57
x
|
3.79
x
|
3.21
x
|
2.74
x
|
EV / Revenue
|
29.3
x
|
15.9
x
|
8.04
x
|
7.34
x
|
3.59
x
|
3.05
x
|
2.57
x
|
EV / EBITDA
|
206
x
|
288
x
|
-147
x
|
433
x
|
-88.2
x
|
85.6
x
|
32.1
x
|
EV / FCF
|
-76.4
x
|
372
x
|
-129
x
|
116
x
|
-122
x
|
143
x
|
51
x
|
FCF Yield
|
-1.31%
|
0.27%
|
-0.78%
|
0.86%
|
-0.82%
|
0.7%
|
1.96%
|
Price to Book
|
21.5
x
|
19.2
x
|
8.23
x
|
7.93
x
|
4.88
x
|
4.74
x
|
4.37
x
|
Nbr of stocks (in thousands)
|
48,711
|
50,205
|
53,653
|
57,590
|
57,961
|
-
|
-
|
Reference price
2 |
87.29
|
91.27
|
63.56
|
64.92
|
38.42
|
38.42
|
38.42
|
Announcement Date
|
3/9/21
|
2/23/22
|
2/27/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
51.13
|
139.7
|
277
|
383.5
|
493.6
|
587.9
|
693.5
|
812.1
|
EBITDA
1 |
-
|
19.8
|
15.3
|
-20.98
|
8.364
|
-23.95
|
24.71
|
65.03
|
EBIT
1 |
-
|
18.42
|
10.84
|
-28.1
|
-2.371
|
-39.51
|
3.872
|
36.23
|
Operating Margin
|
-
|
13.19%
|
3.92%
|
-7.33%
|
-0.48%
|
-6.72%
|
0.56%
|
4.46%
|
Earnings before Tax (EBT)
1 |
-
|
13.79
|
10.68
|
-26.18
|
4.246
|
-38.52
|
10.6
|
39.38
|
Net income
1 |
-
|
13.79
|
9.84
|
-29.27
|
-1.636
|
-30.75
|
13.06
|
30.9
|
Net margin
|
-
|
9.87%
|
3.55%
|
-7.63%
|
-0.33%
|
-5.23%
|
1.88%
|
3.81%
|
EPS
2 |
-0.1400
|
0.2700
|
0.1800
|
-0.5500
|
-0.0300
|
-0.5300
|
0.2238
|
0.5280
|
Free Cash Flow
1 |
-
|
-53.52
|
11.84
|
-23.92
|
31.22
|
-17.3
|
14.8
|
40.9
|
FCF margin
|
-
|
-38.32%
|
4.27%
|
-6.24%
|
6.32%
|
-2.94%
|
2.13%
|
5.04%
|
FCF Conversion (EBITDA)
|
-
|
-
|
77.42%
|
-
|
373.23%
|
-
|
59.88%
|
62.89%
|
FCF Conversion (Net income)
|
-
|
-
|
120.34%
|
-
|
-
|
-
|
113.34%
|
132.36%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/21/20
|
3/9/21
|
2/23/22
|
2/27/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
72.92
|
83.22
|
86.75
|
92.74
|
96.2
|
107.8
|
116.2
|
119
|
126.4
|
132.1
|
137.8
|
140.5
|
150
|
159.5
|
162.6
|
EBITDA
1 |
-1.907
|
3.444
|
-1.983
|
-8.095
|
-8.018
|
-4.001
|
-2.365
|
0.63
|
4.285
|
3.131
|
-8.612
|
-7.751
|
-3.972
|
0.4292
|
16
|
EBIT
1 |
-2.727
|
1.746
|
-3.082
|
-9.328
|
-9.798
|
-5.891
|
-5.338
|
-1.51
|
2.113
|
-0.319
|
-14.02
|
-12.75
|
-8.856
|
-4.266
|
0.25
|
Operating Margin
|
-3.74%
|
2.1%
|
-3.55%
|
-10.06%
|
-10.18%
|
-5.47%
|
-4.6%
|
-1.27%
|
1.67%
|
-0.24%
|
-10.18%
|
-9.08%
|
-5.9%
|
-2.67%
|
0.15%
|
Earnings before Tax (EBT)
1 |
-2.743
|
1.681
|
-3.129
|
-8.935
|
-9.313
|
-4.808
|
-1.194
|
3.024
|
5.59
|
-3.176
|
-13.89
|
-12.01
|
-8.647
|
-3.134
|
1.8
|
Net income
1 |
-2.804
|
1.107
|
-3.129
|
-10.19
|
-10.15
|
-5.798
|
-2.218
|
2.085
|
3.162
|
-4.667
|
-10.96
|
-10.25
|
-6.205
|
-1.691
|
1.8
|
Net margin
|
-3.85%
|
1.33%
|
-3.61%
|
-10.98%
|
-10.55%
|
-5.38%
|
-1.91%
|
1.75%
|
2.5%
|
-3.53%
|
-7.96%
|
-7.3%
|
-4.14%
|
-1.06%
|
1.11%
|
EPS
2 |
-0.0600
|
0.0200
|
-0.0600
|
-0.1900
|
-0.1900
|
-0.1100
|
-0.0400
|
0.0400
|
0.0500
|
-0.0800
|
-0.1925
|
-0.1850
|
-0.1150
|
-0.0400
|
0.0300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/9/21
|
2/23/22
|
5/4/22
|
8/3/22
|
11/2/22
|
2/27/23
|
5/3/23
|
8/2/23
|
11/1/23
|
2/28/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
164
|
176
|
326
|
115
|
114
|
111
|
139
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-53.5
|
11.8
|
-23.9
|
31.2
|
-17.3
|
14.8
|
40.9
|
ROE (net income / shareholders' equity)
|
-
|
17.1%
|
4.48%
|
-8.92%
|
2.27%
|
-0.27%
|
3.37%
|
8.56%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
1.7%
|
-4%
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-96.15
|
768.7
|
-
|
-
|
Book Value Per Share
2 |
-
|
4.070
|
4.750
|
7.720
|
8.190
|
7.880
|
8.110
|
8.790
|
Cash Flow per Share
2 |
-
|
0.0400
|
-
|
-0.2600
|
0.6300
|
0.4300
|
0.4900
|
-
|
Capex
1 |
-
|
5.46
|
-
|
9.95
|
4.71
|
7.7
|
8.8
|
10.7
|
Capex / Sales
|
-
|
3.91%
|
-
|
2.59%
|
0.95%
|
1.31%
|
1.27%
|
1.32%
|
Announcement Date
|
2/21/20
|
3/9/21
|
2/23/22
|
2/27/23
|
2/28/24
|
-
|
-
|
-
|
Last Close Price
38.42
USD Average target price
71.3
USD Spread / Average Target +85.58% Consensus |
1st Jan change
|
Capi.
|
---|
| -40.82% | 2.23B | | +73.17% | 12.38B | | -18.74% | 7.92B | | +16.15% | 7.2B | | +4.81% | 5.84B | | +5.99% | 5.01B | | +27.07% | 4.53B | | -21.67% | 3.88B | | +1.49% | 2.02B | | +5.07% | 1.88B |
Medical Equipment
|